Differences in BRCA Counseling and Testing Practices Based on Ordering Provider Type

摘要: The purpose of this study was to assess potential differences in genetic counseling services delivered by board-certified health-care providers versus non–genetic providers. We evaluated (i) patient recall and content pretest for hereditary breast ovarian cancer (ii) whether full BRCA1 2 gene sequencing performed when less expensive single-site or Ashkenazi Jewish founder mutation testing may have been sufficient. Participants completed a questionnaire provided BRCA test reports that included provider type test. Chi-square tests logistic regression were used analysis. Of 473 participants, >90% white, female, carriers. the 276 (58%) with involvement, 97% recalled discussion as compared 59% those without involvement (P < 0.001). Among subgroup who (n = 385), indicated higher adherence eight recognized elements, four which statistically significant. Furthermore, halved likelihood comprehensive ordered among 266 whom multisite-3 sufficient 0.02). Our results suggest is associated nationally recommended practices could potentially reduce costs testing. Genet Med advance online publication 12 June 2014